Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00249
|
|||||
| Drug Name |
Cannabidiol
|
|||||
| Synonyms |
(-)-CBD; (-)-Cannabidiol; (-)-trans-2-p-Mentha-1,8-dien-3-yl-5-pentylresorcinol; (-)-trans-Cannabidiol; 19GBJ60SN5; CBD; Epidiolex; GWP42003-P; QHMBSVQNZZTUGM-ZWKOTPCHSA-N; UNII-19GBJ60SN5; delta1(2)-trans-Cannabidiol
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Lennox-Gastaut syndrome [ICD11:8A62.1] | Approved | [1] | |||
| Dravet syndrome [ICD11:8A61.11] | Approved | [1] | ||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C21H30O2
|
|||||
| Canonical SMILES |
CCCCCC1=CC(=C(C(=C1)O)C2C=C(CCC2C(=C)C)C)O
|
|||||
| InChI |
InChI=1S/C21H30O2/c1-5-6-7-8-16-12-19(22)21(20(23)13-16)18-11-15(4)9-10-17(18)14(2)3/h11-13,17-18,22-23H,2,5-10H2,1,3-4H3/t17-,18+/m0/s1
|
|||||
| InChIKey |
QHMBSVQNZZTUGM-ZWKOTPCHSA-N
|
|||||
| CAS Number |
CAS 145514-04-1
|
|||||
| Pharmaceutical Properties | Molecular Weight | 314.5 | Topological Polar Surface Area | 40.5 | ||
| Heavy Atom Count | 23 | Rotatable Bond Count | 6 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 2 | |||
| XLogP |
6.5
|
|||||
| PubChem CID | ||||||
| PubChem SID |
103460177
,104014242
,104152845
,109827355
,113635231
,12012585
,134990571
,135697550
,136213730
,142472550
,14825860
,14899058
,160711726
,162224688
,178100971
,198983043
,224092533
,226491388
,242059005
,24892861
,250138861
,252159978
,252415453
,43765781
,57309735
,57408178
,57654032
,80649036
,841235
,8707245
|
|||||
| ChEBI ID |
CHEBI:69478
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Cannabidiol was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017 Jan 4;45(D1):D353-D361. (dg:DG01665) | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.